Western blot confirmed that shRNA1 efficiently knocked down BCL9 in both DCIS.COM (Fig. 4a; left panel) and SUM225 (Fig. 4a; right panel). The gene discussed is BCL9; the disease is ductal breast carcinoma in situ.